Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Corticorelin (Acthrel) vs Ziconotide (Prialt)
An educational, source-based comparison of Corticorelin (Acthrel) and Ziconotide (Prialt) — how each peptide works, what it's researched for, and what to know before going deeper.
Synthetic ovine CRH for differential diagnosis of Cushing's syndrome.
Synthetic ovine corticotropin-releasing hormone (oCRH) that stimulates pituitary ACTH release; used in inferior petrosal sinus sampling and peripheral CRH stimulation testing to distinguish pituitary from ectopic ACTH-dependent Cushing's syndrome.
- Differential diagnosis of ACTH-dependent Cushing's syndrome
- • FDA-approved.
- • Transient flushing, dyspnea, hypotension possible.
Synthetic ω-conopeptide for severe chronic pain via intrathecal infusion.
Synthetic version of ω-conotoxin MVIIA from cone snail Conus magus; selectively blocks N-type voltage-gated calcium channels on primary afferent nerve terminals in the spinal dorsal horn, inhibiting nociceptive neurotransmitter release.
- Severe chronic pain refractory to systemic analgesics, intrathecal morphine
- • FDA-approved.
- • Black-box warning for severe psychiatric and neurologic effects.
- • Contraindicated in history of psychosis.
Corticorelin (Acthrel) vs Ziconotide (Prialt) — Key differences
- Class: Corticorelin (Acthrel) is classified as CRH Analog · Diagnostics, while Ziconotide (Prialt) is N-type Calcium Channel Blocker · Analgesic.
- Primary research focus: Corticorelin (Acthrel) — differential diagnosis of acth-dependent cushing's syndrome; Ziconotide (Prialt) — severe chronic pain refractory to systemic analgesics, intrathecal morphine.
- Tag: FDA-Approved · Diagnostics vs FDA-Approved · Pain.